```

πŸ’Š HIMS Institutional Bets $7.3M on Telehealth Breakout! πŸš€

Institutional whale alert: $725.0M premium detected on HIMS options (1420x average size). Massive institutional activity hit HIMS today with $7.3M in total premium across five major trades! The big money is loading up on $59 calls with $2M ... Full analysis reveals gamma exposure levels, catalyst ti

πŸ“… October 3, 2025 | πŸ”₯ Unusual Activity Detected

🎯 The Quick Take

Massive institutional activity hit HIMS today with $7.3M in total premium across five major trades! The big money is loading up on $59 calls with $2M premium at the ask - that's aggressive bullish positioning ahead of international expansion. With GLP-1 regulatory clarity coming and Canada launch in 2026, institutions are betting on a breakout. Translation: Smart money sees a major catalyst brewing here!


πŸ“Š Company Overview

Hims & Hers Health (HIMS) is a vertically integrated telehealth platform with:
- Market Cap: $13.1 Billion
- Industry: Services-Offices & Clinics of Doctors of Medicine
- Primary Business: Telehealth platform for erectile dysfunction, hair loss, skin care, mental health, and weight loss
- Subscribers: 2.4 million (31% YoY growth)


πŸ’° The Option Flow Breakdown

πŸ“Š The Tape (October 3, 2025)

Time Symbol Side Buy/Sell Type Expiration Premium Strike Volume OI Size Spot Option Price Option Symbol
10:24:13 HIMS ABOVE ASK BUY CALL 2025-10-10 $2M $59 10K 1.9K 10,000 $57.36 $2.02 HIMS20251010C59
13:23:25 HIMS ASK BUY CALL 2025-10-10 $1.8M $58 13K 1K 10,000 $55.05 $1.75 HIMS20251010C58
12:13:20 HIMS MID BUY CALL 2025-10-10 $1.2M $60 11K 6.9K 7,500 $57.64 $1.62 HIMS20251010C60
13:23:25 HIMS BID SELL PUT 2025-10-10 $1.2M $50 18K 2.3K 10,000 $55.05 $1.17 HIMS20251010P50
10:24:13 HIMS BID SELL PUT 2025-10-10 $930K $52 10K 1.8K 10,000 $57.36 $0.93 HIMS20251010P52

πŸ€“ What This Actually Means

Real talk: This is UNPRECEDENTED activity for HIMS! The unusual score hits 8.0 out of 10 - that's 1420x larger than average daily premium. This happens maybe once a year! Here's the breakdown:

βœ… Three massive call purchases totaling $5M in premium - institutions betting on upside
βœ… Two put sales for $2.1M premium - collecting income while providing downside support
βœ… $59 strike calls bought ABOVE ASK - someone needed to get filled NOW
βœ… All October 10 expiration - positioned for near-term catalyst (7 days away!)
βœ… Heavy concentration at $58-60 strikes - expecting breakout above current levels

The combination of aggressive call buying and put selling creates a bullish synthetic position - big money expects movement up!


πŸ“ˆ Technical Setup / Chart Check-Up

YTD Performance Chart

HIMS YTD Performance

HIMS showing impressive +165% YTD gains, absolutely crushing the market! After bottoming around $20 in January, the stock has been on a tear. Key observations:

  • Massive momentum: Stock tripled from January lows
  • Recent consolidation: Trading in $50-58 range since August
  • Volume surge: Today's option activity coincides with increased volume
  • Ready to breakout: Coiling at resistance near $58

Gamma-Based Support & Resistance Analysis

HIMS Gamma Support/Resistance

Current Price: $54.05

The gamma landscape reveals critical levels explaining today's institutional positioning:

πŸ”΅ Put Gamma Support Levels:
- $54 strike: Major support right at current price (13.5M total gamma)
- $53 strike: Strong floor with 12.8M gamma concentration
- $50 strike: Deep support at 9.0M gamma (massive put wall)
- $45 strike: Ultimate floor with 4.1M gamma

🟠 Call Gamma Resistance Levels:
- $55 strike: Immediate resistance with 24.1M total gamma (strongest level!)
- $56 strike: Moderate resistance at 4.6M gamma
- $57 strike: Breaking point with 5.4M gamma
- $60 strike: Target zone with 5.9M gamma

Translation: We're sitting RIGHT at the $54 support with massive resistance at $55. Once we clear $55, it's smooth sailing to $60! That's exactly why institutions loaded $58-$60 calls today.


πŸŽͺ Catalysts

⏰ Upcoming Events

GLP-1 Regulatory Decision - Q4 2025
- FDA clarifying policies on compounded GLP-1s as supply stabilizes
- HIMS adapting with personalized dosing and branded partnerships
- Weight-loss business targeting $725M in 2025 revenue

Canadian Market Launch - January 2026
- First international expansion with generic GLP-1s
- Two-thirds of Canadians overweight/obese = massive TAM
- Branded semaglutide costs C$200+ monthly vs generic opportunity

Q3 2025 Earnings - Late October
- Consensus expecting continued 40%+ revenue growth
- Focus on subscriber additions and retention metrics
- Core business (ex-GLP-1) grew 43% to $1.2B in 2024

βœ… Recently Completed

ZAVA Acquisition - Q3 2025
- Brings 1M+ European customers and telehealth presence
- Establishes presence in Germany, France, Ireland, UK
- Platform for European GLP-1 expansion

Q2 2025 Results - August 5
- Revenue $544.8M (+73% YoY) slightly missed $552M consensus
- 2.4M subscribers with $84 monthly revenue per user
- Only 25% GLP-1 discontinuation vs 80% industry-wide


🎲 Price Targets & Probabilities

Based on gamma levels and catalyst timing:

πŸš€ Bull Case (30% chance)

Target: $60+ by October 10
- Clear the massive $55 gamma wall on positive catalyst
- Options expire at $60 strike where institutions loaded up
- Canada expansion news or GLP-1 clarity drives breakout
- Test $60 resistance where 5.9M gamma sits

😐 Base Case (50% chance)

Target: $54-57 range
- Remain pinned between $54 support and $55 resistance
- Gamma gravity keeps price in current consolidation
- Wait for earnings late October for next move
- Theta decay hurts option premiums

😰 Bear Case (20% chance)

Target: $50-53 support zone
- Fail at $55 resistance again
- Test major put support at $53 (12.8M gamma)
- Ultimate floor at $50 where massive put wall sits
- Regulatory concerns resurface on GLP-1


πŸ’‘ Trading Ideas

πŸ›‘οΈ Conservative: Sell Cash-Secured Puts

  • Strike: $52 Put
  • Expiration: October 10, 2025
  • Premium: ~$0.93 per contract
  • Why it works: Collect premium with support at $52-53 gamma wall. Get assigned at attractive entry if it dips.

βš–οΈ Balanced: Bull Call Spread

  • Buy: $55 Call at ~$1.50
  • Sell: $58 Call at ~$0.80
  • Net Debit: $0.70 per spread
  • Max Profit: $2.30 (329% return) if above $58
  • Why it works: Profit from breakout above $55 resistance with limited risk

πŸš€ Aggressive: Follow the Whale

  • Buy: $59 Calls at ~$1.00
  • Expiration: October 10, 2025
  • Risk: 100% premium loss if below $59
  • Why it works: Ride coattails of $2M institutional bet. They bought above ask for a reason!

⚠️ Risk Factors

Let's keep it real - here's what could go wrong:

❌ FDA crackdown on compounded GLP-1s - Stricter oversight already happening
❌ Competition from big pharma - Novo Nordisk and Lilly protecting turf
❌ October 10 expiration - Only 7 days for this to work!
❌ High implied volatility - Options expensive, need big move to profit
❌ $55 gamma wall rejection - Heavy resistance could cap upside


🎯 The Bottom Line

Real talk: Someone just bet $7.3M that HIMS breaks out within the next week! The unusual score of 8.0 (1420x average size) tells us this isn't your neighbor Bob - this is serious institutional money positioning ahead of something.

If you own HIMS: Hold tight! The gamma setup shows strong support at $54 with breakout potential to $60.

If you're watching: The $55 level is KEY. Break above with volume = potential entry. Rejection = wait for $52-53 support.

If you're bearish: Respect the $50 put wall - that's major institutional support. Better opportunities elsewhere.

Mark your calendar: October 10 expiration means fireworks by next Thursday. Late October earnings provide next catalyst if this trade doesn't hit.

Remember: Options are risky! This $7.3M whale can afford to lose - make sure you position size appropriately! πŸ’ͺ


Disclaimer: This is analysis of unusual options activity, not financial advice. Options involve risk of 100% loss. Always do your own research and consult with a financial advisor.

Subscribe to AInvest Option Labs

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe